Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Anticancer Activity of HER2-targeting CPP-PTEN-THP Chimeric Proteins.
Anticancer Res. 2024 Jun;44(6):2567-2575. doi: 10.21873/anticanres.17062.
Anticancer Res. 2024.
PMID: 38821612
Effects of siRNA-mediated Silencing of ERBB2, IGF-1R, and ITGB1 in HER2-positive Breast Cancer Cells.
Hernandez-Juarez J, Gonzalez-Cruz AO, Miranda-Espino R, Ronquillo-Sanchez MD, Ramirez-Estrada K, Balderas-Renteria I, Arredondo-Espinoza E.
Hernandez-Juarez J, et al. Among authors: gonzalez cruz ao.
Cancer Diagn Progn. 2023 Mar 3;3(2):183-188. doi: 10.21873/cdp.10199. eCollection 2023 Mar-Apr.
Cancer Diagn Progn. 2023.
PMID: 36875302
Free PMC article.
Item in Clipboard
Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 Cells In Vitro.
Solis-Estrada J, Arredondo-Espinoza E, Pioquinto-Ávila E, González-Cruz AO, Zarate X, Balderas-Rentería I.
Solis-Estrada J, et al. Among authors: gonzalez cruz ao.
Anticancer Res. 2024 May;44(5):1955-1962. doi: 10.21873/anticanres.16998.
Anticancer Res. 2024.
PMID: 38677771
Item in Clipboard
Cite
Cite